Enanta Pharmaceuticals Stock Forecast

Buy candidate since Jul 17, 2026

The Enanta Pharmaceuticals stock price gained 4.17% on the last trading day (Friday, 17th Jul 2026), rising from $13.19 to $13.74. During the last trading day the stock fluctuated 6.25% from a day low at $13.04 to a day high of $13.85. The price has fallen in 7 of the last 10 days and is down by -9.07% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 24 thousand more shares were traded than the day before. In total, 182 thousand shares were bought and sold for approximately $2.50 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.07% during the next 3 months and, with a 90% probability hold a price between $10.52 and $14.64 at the end of this 3-month period.

ENTA Signals & Forecast

The Enanta Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.55 and $13.07. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, July 14, 2026, and so far it has risen 4.81%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

Enanta Pharmaceuticals finds support from accumulated volume at $13.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.82 between high and low, or 6.25%. For the last week, the stock has had daily average volatility of 4.20%.

Our recommended stop-loss: $13.13 (-4.43%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Enanta Pharmaceuticals to open at $13.54, and during the day (based on 14 day Average True Range), to move between $13.38 and $14.10, which gives a possible trading interval of +/-$0.721 (+/-5.39%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.00 (1.89%) than the support at $13.45 (2.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Enanta Pharmaceuticals stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.152 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $13.54 ( 1.44%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk